Literature DB >> 16783411

Stimulation of sensory neuropeptide release by nociceptin/orphanin FQ leads to hyperaemia in acutely inflamed rat knees.

Chunfen Zhang1, Jason J McDougall.   

Abstract

The peripheral effect of the 'opioid-like' peptide nociceptin/orphanin FQ (N/OFQ) on joint blood flow was investigated in acutely inflamed rats. Sensory neuropeptide release from capsaicin-sensitive nerves and the involvement of synovial mast cells and leukocytes on these vasomotor responses were also studied. Blood flow measurements of exposed knee joints were performed in urethane-anaesthetised rats (2 mg kg(-1) intraperitoneal) using laser Doppler perfusion imaging. Topical administration of N/OFQ (10(-13)-10(-8) mol) to acutely inflamed joints caused a dose-dependent increase in synovial perfusion with an ED(50) of 4.0 x 10(-10) mol. This vasodilatatory response was blocked by the selective NOP receptor antagonist [Phe(1)-(CH(2)-NH)-Gly(2)]-Nociceptin(1-13)-NH(2) (10(-9) mol) (P<0.0001).Co-administration of N/OFQ with the neurokinin-1 (NK(1)) receptor antagonist [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P (10(-12) mol), the vasoactive intestinal peptide (VIP) receptor antagonist VIP(6-28) (10(-9) mol) or the calcitonin gene-related peptide (CGRP) receptor antagonist CGRP(8-37) (10(-9) mol) all blocked the hyperaemic effect of N/OFQ (P<0.0001). Treatment of acutely inflamed knees with capsaicin (8-methyl-N-vanillyl-6-noneamide) to destroy unmyelinated joint afferents also inhibited N/OFQ vasomotor activity. Stabilisation of synovial mast cells with disodium cromoglycate (cromolyn) ameliorated N/OFQ responses, whereas inactivation of circulating leukocytes with the pan-selectin inhibitor fucoidin completely blocked N/OFQ-induced hyperaemia in these joints. These experiments show that in acutely inflamed knee joints, N/OFQ acts on NOP receptors located on synovial mast cells and leukocytes leading to the secondary release of proinflammatory mediators into the joint. These agents subsequently stimulate sensory neuropeptide release from capsaicin-sensitive nerves culminating in vasodilatation and increased articular blood flow.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16783411      PMCID: PMC1751929          DOI: 10.1038/sj.bjp.0706804

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  51 in total

1.  Effect of nociceptin on heart rate and blood pressure in anaesthetized rats.

Authors:  S Giuliani; M Tramontana; A Lecci; C A Maggi
Journal:  Eur J Pharmacol       Date:  1997-08-27       Impact factor: 4.432

2.  Nociceptin/orphanin FQ increases blood pressure and heart rate via sympathetic activation in sheep.

Authors:  M L Arndt; D Wu; Y Soong; H H Szeto
Journal:  Peptides       Date:  1999       Impact factor: 3.750

3.  Nitric oxide release mediates vasodilator responses to endomorphin 1 but not nociceptin/OFQ in the hindquarters vascular bed of the rat.

Authors:  H C Champion; T J Bivalacqua; D E Friedman; J E Zadina; A J Kastin; P J Kadowitz
Journal:  Peptides       Date:  1998       Impact factor: 3.750

Review 4.  Memory mechanisms: the nociceptin connection.

Authors:  Y Goda; M Mutneja
Journal:  Curr Biol       Date:  1998-12-03       Impact factor: 10.834

5.  Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat.

Authors:  C R Neal; A Mansour; R Reinscheid; H P Nothacker; O Civelli; S J Watson
Journal:  J Comp Neurol       Date:  1999-04-19       Impact factor: 3.215

6.  Effects of intrathecal orphanin FQ on a flexor reflex in the rat after inflammation or peripheral nerve section.

Authors:  I S Xu; S Grass; Z Wiesenfeld-Hallin; X J Xu
Journal:  Eur J Pharmacol       Date:  1999-04-01       Impact factor: 4.432

7.  Nociceptin/orphanin FQ-induced nociceptive responses through substance P release from peripheral nerve endings in mice.

Authors:  M Inoue; M Kobayashi; S Kozaki; A Zimmer; H Ueda
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

8.  Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies.

Authors:  R Bigoni; S Giuliani; G Calo'; A Rizzi; R Guerrini; S Salvadori; D Regoli; C A Maggi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1999-03       Impact factor: 3.000

9.  Nociceptin, a novel endogenous ligand for the ORL1 receptor, dilates isolated resistance arteries from the rat.

Authors:  H C Champion; R L Pierce; P J Kadowitz
Journal:  Regul Pept       Date:  1998-11-30

Review 10.  Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more.

Authors:  T Darland; M M Heinricher; D K Grandy
Journal:  Trends Neurosci       Date:  1998-05       Impact factor: 13.837

View more
  7 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

2.  Direct inhibition of hypocretin/orexin neurons in the lateral hypothalamus by nociceptin/orphanin FQ blocks stress-induced analgesia in rats.

Authors:  Dmitry Gerashchenko; Tamas L Horvath; Xinmin Simon Xie
Journal:  Neuropharmacology       Date:  2010-12-30       Impact factor: 5.250

3.  In vivo effects of CB2 receptor-selective cannabinoids on the vasculature of normal and arthritic rat knee joints.

Authors:  J J McDougall; V Yu; J Thomson
Journal:  Br J Pharmacol       Date:  2007-11-05       Impact factor: 8.739

4.  ZP120 causes relaxation by pre-junctional inhibition of noradrenergic neurotransmission in rat mesenteric resistance arteries.

Authors:  U Simonsen; B E Laursen; J S Petersen
Journal:  Br J Pharmacol       Date:  2008-01-14       Impact factor: 8.739

5.  The nociceptin/orphanin FQ receptor system as a target to alleviate cancer-induced bone pain in rats: Model validation and pharmacological evaluation.

Authors:  Sonny H J Sliepen; Johanna Korioth; Thomas Christoph; Thomas M Tzschentke; Marta Diaz-delCastillo; Anne-Marie Heegaard; Kris Rutten
Journal:  Br J Pharmacol       Date:  2020-01-21       Impact factor: 8.739

6.  NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases.

Authors:  Elaine C Gavioli; Pedro R T Romão
Journal:  J Amino Acids       Date:  2011-11-17

Review 7.  Arthritis and pain. Neurogenic origin of joint pain.

Authors:  Jason J McDougall
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.